| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population.
|
Nature
|
2005
|
6.78
|
|
2
|
Short interfering RNA confers intracellular antiviral immunity in human cells.
|
Nature
|
2002
|
5.27
|
|
3
|
The RNA silencing endonuclease Argonaute 2 mediates specific antiviral immunity in Drosophila melanogaster.
|
Genes Dev
|
2006
|
4.26
|
|
4
|
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.
|
Cell
|
2010
|
4.07
|
|
5
|
Quasispecies theory and the behavior of RNA viruses.
|
PLoS Pathog
|
2010
|
3.19
|
|
6
|
Engineering attenuated virus vaccines by controlling replication fidelity.
|
Nat Med
|
2008
|
3.01
|
|
7
|
The endocytic pathway mediates cell entry of dsRNA to induce RNAi silencing.
|
Nat Cell Biol
|
2006
|
2.83
|
|
8
|
High-throughput DNA sequencing errors are reduced by orders of magnitude using circle sequencing.
|
Proc Natl Acad Sci U S A
|
2013
|
2.44
|
|
9
|
Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase.
|
J Biol Chem
|
2005
|
2.40
|
|
10
|
Temporal analysis of the honey bee microbiome reveals four novel viruses and seasonal prevalence of known viruses, Nosema, and Crithidia.
|
PLoS One
|
2011
|
2.23
|
|
11
|
Antiviral immunity in Drosophila requires systemic RNA interference spread.
|
Nature
|
2009
|
2.15
|
|
12
|
Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches.
|
J Virol
|
2005
|
1.98
|
|
13
|
Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines.
|
Cell Host Microbe
|
2008
|
1.94
|
|
14
|
Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance.
|
Genes Dev
|
2007
|
1.87
|
|
15
|
Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing.
|
J Virol
|
2003
|
1.81
|
|
16
|
Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications.
|
Virus Res
|
2005
|
1.81
|
|
17
|
Ribavirin's antiviral mechanism of action: lethal mutagenesis?
|
J Mol Med (Berl)
|
2001
|
1.59
|
|
18
|
Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.
|
J Virol
|
2008
|
1.58
|
|
19
|
Cricket paralysis virus antagonizes Argonaute 2 to modulate antiviral defense in Drosophila.
|
Nat Struct Mol Biol
|
2010
|
1.54
|
|
20
|
The role of mutational robustness in RNA virus evolution.
|
Nat Rev Microbiol
|
2013
|
1.54
|
|
21
|
Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection.
|
J Gen Virol
|
2002
|
1.46
|
|
22
|
Structural and functional characterization of the coxsackievirus B3 CRE(2C): role of CRE(2C) in negative- and positive-strand RNA synthesis.
|
J Gen Virol
|
2006
|
1.39
|
|
23
|
Codon usage determines the mutational robustness, evolutionary capacity, and virulence of an RNA virus.
|
Cell Host Microbe
|
2012
|
1.32
|
|
24
|
Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin.
|
Microbes Infect
|
2002
|
1.29
|
|
25
|
The silent treatment: RNAi as a defense against virus infection in mammals.
|
Trends Biotechnol
|
2006
|
1.27
|
|
26
|
Rationalizing the development of live attenuated virus vaccines.
|
Nat Biotechnol
|
2010
|
1.26
|
|
27
|
An RNA element at the 5'-end of the poliovirus genome functions as a general promoter for RNA synthesis.
|
PLoS Pathog
|
2010
|
1.14
|
|
28
|
The poliovirus 2C cis-acting replication element-mediated uridylylation of VPg is not required for synthesis of negative-sense genomes.
|
J Gen Virol
|
2003
|
1.13
|
|
29
|
Solution structure of a consensus stem-loop D RNA domain that plays important roles in regulating translation and replication in enteroviruses and rhinoviruses.
|
Biochemistry
|
2004
|
1.08
|
|
30
|
Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element.
|
Nucleic Acids Res
|
2006
|
1.05
|
|
31
|
The poliovirus replication machinery can escape inhibition by an antiviral drug that targets a host cell protein.
|
J Virol
|
2004
|
1.04
|
|
32
|
Single-cell analysis uncovers extensive biological noise in poliovirus replication.
|
J Virol
|
2014
|
1.02
|
|
33
|
Non-specific dsRNA-mediated antiviral response in the honey bee.
|
PLoS One
|
2013
|
1.00
|
|
34
|
Poliovirus infection blocks ERGIC-to-Golgi trafficking and induces microtubule-dependent disruption of the Golgi complex.
|
J Cell Sci
|
2007
|
1.00
|
|
35
|
Identification and manipulation of the molecular determinants influencing poliovirus recombination.
|
PLoS Pathog
|
2013
|
0.98
|
|
36
|
Exploring the fitness landscape of an RNA virus by using a universal barcode microarray.
|
J Virol
|
2011
|
0.97
|
|
37
|
Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus.
|
PLoS One
|
2013
|
0.93
|
|
38
|
Extending the family of UNCG-like tetraloop motifs: NMR structure of a CACG tetraloop from coxsackievirus B3.
|
Biochemistry
|
2003
|
0.92
|
|
39
|
RNA interference-mediated intrinsic antiviral immunity in invertebrates.
|
Curr Top Microbiol Immunol
|
2013
|
0.92
|
|
40
|
NMR structures of loop B RNAs from the stem-loop IV domain of the enterovirus internal ribosome entry site: a single C to U substitution drastically changes the shape and flexibility of RNA.
|
Biochemistry
|
2004
|
0.92
|
|
41
|
A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus.
|
Antimicrob Agents Chemother
|
2008
|
0.91
|
|
42
|
Manganese-dependent polioviruses caused by mutations within the viral polymerase.
|
J Virol
|
2003
|
0.90
|
|
43
|
Specific recognition of the C-rich strand of human telomeric DNA and the RNA template of human telomerase by the first KH domain of human poly(C)-binding protein-2.
|
J Biol Chem
|
2004
|
0.89
|
|
44
|
Poliovirus vaccine strains as mucosal vaccine vectors and their potential use to develop an AIDS vaccine.
|
Adv Drug Deliv Rev
|
2004
|
0.89
|
|
45
|
RNA silencing in viral infections: insights from poliovirus.
|
Virus Res
|
2004
|
0.85
|
|
46
|
StralSV: assessment of sequence variability within similar 3D structures and application to polio RNA-dependent RNA polymerase.
|
BMC Bioinformatics
|
2011
|
0.83
|
|
47
|
Global RNA structure analysis of poliovirus identifies a conserved RNA structure involved in viral replication and infectivity.
|
J Virol
|
2013
|
0.81
|
|
48
|
Closing the gap: the challenges in converging theoretical, computational, experimental and real-life studies in virus evolution.
|
Curr Opin Virol
|
2012
|
0.81
|
|
49
|
An enhanced single base extension technique for the analysis of complex viral populations.
|
PLoS One
|
2009
|
0.80
|
|
50
|
Studies towards the potential of poliovirus as a vector for the expression of HPV 16 virus-like-particles.
|
FEMS Immunol Med Microbiol
|
2002
|
0.79
|
|
51
|
RNAi puts a lid on virus replication.
|
Nat Biotechnol
|
2003
|
0.79
|
|
52
|
Slicer activity in Drosophila melanogaster S2 extract.
|
Methods Mol Biol
|
2011
|
0.78
|
|
53
|
Exploring RNA virus replication in Xenopus oocytes.
|
Methods Mol Biol
|
2006
|
0.78
|
|
54
|
Poliovirus: generation, quantification, propagation, purification, and storage.
|
Curr Protoc Microbiol
|
2013
|
0.77
|
|
55
|
Poliovirus: generation and characterization of mutants.
|
Curr Protoc Microbiol
|
2013
|
0.76
|
|
56
|
RNA structure analysis of viruses using SHAPE.
|
Curr Protoc Microbiol
|
2013
|
0.75
|
|
57
|
RNA Recombination Enhances Adaptability and Is Required for Virus Spread and Virulence.
|
Cell Host Microbe
|
2017
|
0.75
|